MATINAS BIOPHARMA HLDGS INC - COM (MTNB)

CUSIP: 576810105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
27,168,050
Share change
+1,976,762
Total reported value
$21,476,641
Price per share
$0.79
Number of holders
46
Value change
+$1,558,684
Number of buys
13
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q2 2022

As of 30 Jun 2022, MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,168,050 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Sargent Investment Group, LLC, NEVILLE RODIE & SHAW INC, GEODE CAPITAL MANAGEMENT, LLC, Arkadios Wealth Advisors, JTC Employer Solutions Trustee Ltd, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and STALEY CAPITAL ADVISERS INC. This page lists 46 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.